Logo image of MDWD

MEDIWOUND LTD (MDWD) Stock Fundamental Analysis

USA - NASDAQ:MDWD - IL0011316309 - Common Stock

18.55 USD
+0.48 (+2.66%)
Last: 10/30/2025, 8:24:23 PM
Fundamental Rating

2

Taking everything into account, MDWD scores 2 out of 10 in our fundamental rating. MDWD was compared to 192 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of MDWD have multiple concerns. MDWD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MDWD had negative earnings in the past year.
In the past year MDWD has reported a negative cash flow from operations.
In the past 5 years MDWD always reported negative net income.
MDWD had a negative operating cash flow in each of the past 5 years.
MDWD Yearly Net Income VS EBIT VS OCF VS FCFMDWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

MDWD has a Return On Assets of -41.72%. This is comparable to the rest of the industry: MDWD outperforms 44.79% of its industry peers.
With a Return On Equity value of -138.93%, MDWD is not doing good in the industry: 66.15% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -41.72%
ROE -138.93%
ROIC N/A
ROA(3y)-30.14%
ROA(5y)-37.73%
ROE(3y)-99.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDWD Yearly ROA, ROE, ROICMDWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

MDWD has a Gross Margin (18.43%) which is comparable to the rest of the industry.
MDWD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MDWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.33%
GM growth 5Y-26.97%
MDWD Yearly Profit, Operating, Gross MarginsMDWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

2

2. Health

2.1 Basic Checks

MDWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
MDWD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MDWD has been increased compared to 5 years ago.
MDWD has a better debt/assets ratio than last year.
MDWD Yearly Shares OutstandingMDWD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MDWD Yearly Total Debt VS Total AssetsMDWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

A Debt/Equity ratio of 0.40 indicates that MDWD is not too dependend on debt financing.
MDWD's Debt to Equity ratio of 0.40 is in line compared to the rest of the industry. MDWD outperforms 41.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.66%
MDWD Yearly LT Debt VS Equity VS FCFMDWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 1.48 indicates that MDWD should not have too much problems paying its short term obligations.
MDWD has a Current ratio of 1.48. This is in the lower half of the industry: MDWD underperforms 69.27% of its industry peers.
MDWD has a Quick Ratio of 1.35. This is a normal value and indicates that MDWD is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.35, MDWD is not doing good in the industry: 64.58% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.35
MDWD Yearly Current Assets VS Current LiabilitesMDWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for MDWD have decreased strongly by -22.22% in the last year.
MDWD shows a decrease in Revenue. In the last year, the revenue decreased by -1.42%.
The Revenue has been decreasing by -8.65% on average over the past years.
EPS 1Y (TTM)-22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.88%
Revenue 1Y (TTM)-1.42%
Revenue growth 3Y-5.23%
Revenue growth 5Y-8.65%
Sales Q2Q%12.74%

3.2 Future

MDWD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.12% yearly.
The Revenue is expected to grow by 41.51% on average over the next years. This is a very strong growth
EPS Next Y8.58%
EPS Next 2Y8.19%
EPS Next 3Y8.72%
EPS Next 5Y18.12%
Revenue Next Year19.48%
Revenue Next 2Y21.23%
Revenue Next 3Y19.11%
Revenue Next 5Y41.51%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDWD Yearly Revenue VS EstimatesMDWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M 250M
MDWD Yearly EPS VS EstimatesMDWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 -4 6 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MDWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MDWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDWD Price Earnings VS Forward Price EarningsMDWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDWD Per share dataMDWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.19%
EPS Next 3Y8.72%

More info and screens

0

5. Dividend

5.1 Amount

MDWD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDIWOUND LTD

NASDAQ:MDWD (10/30/2025, 8:24:23 PM)

18.55

+0.48 (+2.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-18 2025-11-18
Inst Owners36.68%
Inst Owner Change1.36%
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap237.81M
Revenue(TTM)19.86M
Net Income(TTM)-27952000
Analysts83.33
Price Target31.28 (68.63%)
Short Float %10.17%
Short Ratio8.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.66%
Min EPS beat(2)-110.94%
Max EPS beat(2)89.63%
EPS beat(4)2
Avg EPS beat(4)-24.03%
Min EPS beat(4)-116.72%
Max EPS beat(4)89.63%
EPS beat(8)4
Avg EPS beat(8)-30.38%
EPS beat(12)5
Avg EPS beat(12)-23.64%
EPS beat(16)7
Avg EPS beat(16)-18.97%
Revenue beat(2)0
Avg Revenue beat(2)-13.42%
Min Revenue beat(2)-25.41%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-14.04%
Min Revenue beat(4)-28.91%
Max Revenue beat(4)-0.39%
Revenue beat(8)1
Avg Revenue beat(8)-7.1%
Revenue beat(12)4
Avg Revenue beat(12)1.97%
Revenue beat(16)6
Avg Revenue beat(16)1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-31.76%
Revenue NQ rev (1m)1.27%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.98
P/FCF N/A
P/OCF N/A
P/B 11.82
P/tB 11.86
EV/EBITDA N/A
EPS(TTM)-2.64
EYN/A
EPS(NY)-2.55
Fwd EYN/A
FCF(TTM)-1.5
FCFYN/A
OCF(TTM)-1.19
OCFYN/A
SpS1.55
BVpS1.57
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -41.72%
ROE -138.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.43%
FCFM N/A
ROA(3y)-30.14%
ROA(5y)-37.73%
ROE(3y)-99.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.33%
GM growth 5Y-26.97%
F-Score2
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 265.85%
Cap/Sales 20.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.35
Altman-Z N/A
F-Score2
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)321.06%
Cap/Depr(5y)217.42%
Cap/Sales(3y)22.58%
Cap/Sales(5y)14.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.88%
EPS Next Y8.58%
EPS Next 2Y8.19%
EPS Next 3Y8.72%
EPS Next 5Y18.12%
Revenue 1Y (TTM)-1.42%
Revenue growth 3Y-5.23%
Revenue growth 5Y-8.65%
Sales Q2Q%12.74%
Revenue Next Year19.48%
Revenue Next 2Y21.23%
Revenue Next 3Y19.11%
Revenue Next 5Y41.51%
EBIT growth 1Y-46.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-66.33%
EBIT Next 3Y-5.88%
EBIT Next 5YN/A
FCF growth 1Y-92.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.83%
OCF growth 3YN/A
OCF growth 5YN/A

MEDIWOUND LTD / MDWD FAQ

What is the fundamental rating for MDWD stock?

ChartMill assigns a fundamental rating of 2 / 10 to MDWD.


What is the valuation status of MEDIWOUND LTD (MDWD) stock?

ChartMill assigns a valuation rating of 0 / 10 to MEDIWOUND LTD (MDWD). This can be considered as Overvalued.


How profitable is MEDIWOUND LTD (MDWD) stock?

MEDIWOUND LTD (MDWD) has a profitability rating of 1 / 10.